208 related articles for article (PubMed ID: 29192405)
1. Development of Itraconazole Tablets Containing Viscous KinetiSol Solid Dispersions: In Vitro and In Vivo Analysis in Dogs.
Keen JM; LaFountaine JS; Hughey JR; Miller DA; McGinity JW
AAPS PharmSciTech; 2018 Jul; 19(5):1998-2008. PubMed ID: 29192405
[TBL] [Abstract][Full Text] [Related]
2. Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs.
Yin X; Daintree LS; Ding S; Ledger DM; Wang B; Zhao W; Qi J; Wu W; Han J
Drug Des Devel Ther; 2015; 9():2801-10. PubMed ID: 26060397
[TBL] [Abstract][Full Text] [Related]
3. Fusion processing of itraconazole solid dispersions by kinetisol dispersing: a comparative study to hot melt extrusion.
DiNunzio JC; Brough C; Miller DA; Williams RO; McGinity JW
J Pharm Sci; 2010 Mar; 99(3):1239-53. PubMed ID: 19681106
[TBL] [Abstract][Full Text] [Related]
4. Mucoadhesive amorphous solid dispersions for sustained release of poorly water soluble drugs.
LaFountaine JS; Prasad LK; Miller DA; McGinity JW; Williams RO
Eur J Pharm Biopharm; 2017 Apr; 113():157-167. PubMed ID: 28088635
[TBL] [Abstract][Full Text] [Related]
5. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
[TBL] [Abstract][Full Text] [Related]
6. Preparation of rapidly disintegrating tablets containing itraconazole solid dispersions.
Oshima T; Sonoda R; Ohkuma M; Sunada H
Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1557-62. PubMed ID: 17978511
[TBL] [Abstract][Full Text] [Related]
7. Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions.
DiNunzio JC; Brough C; Miller DA; Williams RO; McGinity JW
Eur J Pharm Sci; 2010 Jun; 40(3):179-87. PubMed ID: 20230894
[TBL] [Abstract][Full Text] [Related]
8. Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methods.
Sim T; Lim C; Lee JW; Kim DW; Kim Y; Kim M; Choi S; Choi HG; Lee ES; Kim KS; Kang W; Oh KT
J Pharm Pharmacol; 2017 Dec; 69(12):1707-1715. PubMed ID: 28872678
[TBL] [Abstract][Full Text] [Related]
9. The use of a new hydrophilic polymer, Kollicoat IR, in the formulation of solid dispersions of Itraconazole.
Janssens S; de Armas HN; Remon JP; Van den Mooter G
Eur J Pharm Sci; 2007 Mar; 30(3-4):288-94. PubMed ID: 17204410
[TBL] [Abstract][Full Text] [Related]
10. Investigation of dissolution enhancement of itraconazole by solid dispersion in superdisintegrants.
Chowdary KP; Rao SS
Drug Dev Ind Pharm; 2000 Nov; 26(11):1207-11. PubMed ID: 11068695
[TBL] [Abstract][Full Text] [Related]
11. Use of Polyvinyl Alcohol as a Solubility-Enhancing Polymer for Poorly Water Soluble Drug Delivery (Part 1).
Brough C; Miller DA; Keen JM; Kucera SA; Lubda D; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):167-79. PubMed ID: 26637232
[TBL] [Abstract][Full Text] [Related]
12. Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing.
Dinunzio JC; Brough C; Hughey JR; Miller DA; Williams RO; McGinity JW
Eur J Pharm Biopharm; 2010 Feb; 74(2):340-51. PubMed ID: 19818402
[TBL] [Abstract][Full Text] [Related]
13. Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol Dispersing.
DiNunzio JC; Hughey JR; Brough C; Miller DA; Williams RO; McGinity JW
Drug Dev Ind Pharm; 2010 Sep; 36(9):1064-78. PubMed ID: 20334539
[TBL] [Abstract][Full Text] [Related]
14. Formulating Amorphous Solid Dispersions: Impact of Inorganic Salts on Drug Release from Tablets Containing Itraconazole-HPMC Extrudate.
Takano R; Maurer R; Jacob L; Stowasser F; Stillhart C; Page S
Mol Pharm; 2020 Aug; 17(8):2768-2778. PubMed ID: 31794228
[TBL] [Abstract][Full Text] [Related]
15. Improved Vemurafenib Dissolution and Pharmacokinetics as an Amorphous Solid Dispersion Produced by KinetiSol® Processing.
Ellenberger DJ; Miller DA; Kucera SU; Williams RO
AAPS PharmSciTech; 2018 Jul; 19(5):1957-1970. PubMed ID: 29541940
[TBL] [Abstract][Full Text] [Related]
16. Lubricant-Induced Crystallization of Itraconazole From Tablets Made of Electrospun Amorphous Solid Dispersion.
Démuth B; Farkas A; Balogh A; Bartosiewicz K; Kállai-Szabó B; Bertels J; Vigh T; Mensch J; Verreck G; Van Assche I; Marosi G; Nagy ZK
J Pharm Sci; 2016 Sep; 105(9):2982-2988. PubMed ID: 27290626
[TBL] [Abstract][Full Text] [Related]
17. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
Sun W; Ni R; Zhang X; Li LC; Mao S
Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
[TBL] [Abstract][Full Text] [Related]
18. Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2).
Brough C; Miller DA; Ellenberger D; Lubda D; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):180-90. PubMed ID: 26863889
[TBL] [Abstract][Full Text] [Related]
19. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
[TBL] [Abstract][Full Text] [Related]
20. Effects of Surfactants on Itraconazole-Hydroxypropyl Methylcellulose Acetate Succinate Solid Dispersion Prepared by Hot Melt Extrusion III: Tableting of Extrudates and Drug Release From Tablets.
Solanki NG; Kathawala M; Serajuddin ATM
J Pharm Sci; 2019 Dec; 108(12):3859-3869. PubMed ID: 31542437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
